US20100124598A1 - Chemoprotectants From Crucifer Seeds And Sprouts - Google Patents

Chemoprotectants From Crucifer Seeds And Sprouts Download PDF

Info

Publication number
US20100124598A1
US20100124598A1 US12/687,490 US68749010A US2010124598A1 US 20100124598 A1 US20100124598 A1 US 20100124598A1 US 68749010 A US68749010 A US 68749010A US 2010124598 A1 US2010124598 A1 US 2010124598A1
Authority
US
United States
Prior art keywords
extract
sprouts
chemoprotectant precursor
kale
chemoprotectant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/687,490
Inventor
Leslie G. West
George W. Haas
Nathan Matusheski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercontinental Great Brands LLC
Original Assignee
Kraft Foods Global Brands LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kraft Foods Global Brands LLC filed Critical Kraft Foods Global Brands LLC
Priority to US12/687,490 priority Critical patent/US20100124598A1/en
Publication of US20100124598A1 publication Critical patent/US20100124598A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Definitions

  • the present invention relates to chemoprotective compounds and method for producing chemoprotective compounds which may be incorporated into a variety of food products. More specifically, an extraction method is provided that is effective for providing an extract having a high ratio of chemoprotective compounds to less desirable compounds while providing a high yield of chemoprotective compounds. Enhanced yields and ratios of chemoprotective compounds are provided by an aqueous extraction method used in combination with adsorbents.
  • Cimmalian vegetables contain phytochemical precursors to potent chemoprotectants especially glucoraphanin and its associated conversion product sulforaphane, that when delivered to mammalian cells trigger carcinogen detoxification mechanisms.
  • glucoraphanin through its bioactive conversion product sulforphane has recently been shown effective in destroying the organism responsible for causing the majority of stomach ulcers and may provide novel approaches for reducing the risk of developing cardiovascular and ocular diseases.
  • Efforts are being undertaken to gain approval for making label claims on food products either naturally high in these agents or for foods containing added crucifer chemoprotectants. Products containing chemoprotectant additives, although without claims, are already on the market.
  • Cruciferous vegetables also contain other compounds, such as indole glucosinolates, which are problematic for maintaining good health. Not only are these compounds weak inducers of the carcinogen detoxification system, but also they can induce systems which may bioactivate certain pro-carcinogens.
  • the breakdown products of indole glucosinolates formed in the stomach during digestion may act in a similar manner to dioxin, a very potent toxin. Therefore, it is advantageous to produce glucoraphanin-containing preparations containing as little residual indole glucosinolates, or other adverse compounds, as possible.
  • the present invention is directed to chemoprotectant precursor compositions provided from crucifer seeds and sprouts and methods for their preparation.
  • Treatment of aqueous extracts from crucifer seeds or sprouts with adsorbents substantially increases the ratio of certain highly chemoprotectant precursor compounds (alkyl glucosinolates such as glucoraphanin, a.k.a. sulforaphane glucosinolate) to undesirable compounds such as indole glucosinolates (for example 4-hydroxyglucobrassicin).
  • alkyl glucosinolates such as glucoraphanin, a.k.a. sulforaphane glucosinolate
  • undesirable compounds such as indole glucosinolates (for example 4-hydroxyglucobrassicin).
  • the method provides an extract which has a ratio of glucoraphanin to 4-hydroxyglucobrassicin of about 70 or greater.
  • a method for extracting chemoprotectants precursors from crucifer seeds or sprouts includes forming an aqueous extract of crucifer seeds or sprouts.
  • the aqueous extract is contacted with an adsorbent.
  • the aqueous extract is separated from the adsorbent to provide a chemoprotectant enhanced extract.
  • the method is effective for providing a chemoprotectant enhanced extract having a ratio of a number of alkyl glucosinolates, especially glucoraphanin to indole glucosinolates, specifically 4-hydroxyglucobrassicin of about 30 to about 1000 or greater, preferably about 100 to about 1000.
  • Crucifer vegetables have been identified as a good source of chemoprotectant precursor phytochemicals.
  • Crucifer seeds and sprouts have been found to be an especially good source of chemoprotectant precursors.
  • Crucifer seeds or sprouts which are especially useful include broccoli, kale, collard, curly kale, marrowstem kale, thousand head kale, Chinese kale, cauliflower, Portuguese kale, Brussels sprouts, kohlrabi, Jersey kale, savoy cabbage, collards, borecole, radish, and the like as well as mixtures thereof.
  • crucifier seeds or seeds and sprouts of broccoli are utilized.
  • crucifer seeds When crucifer seeds are used as a starting material, they may be used directly or may be processed prior to aqueous extraction.
  • crucifer seeds may be defatted prior to forming an aqueous extract using known defatting procedures. For example, West, L. et al., J Agric. Food Chem. 2004, 52, 916-926, which is incorporated herein by reference.
  • crucifer seeds may be ground, pulverized or blended prior to addition of aqueous extract or simultaneously with the addition of an aqueous extract.
  • Extraction of seed or sprouts may be conducted with water or water containing an organic solvent, such as ethyl alcohol.
  • an aqueous extract of crucifer seeds or sprouts is formed by contacting crucifer seeds or sprouts with water having a temperature of 60 to 110° C. for at least 5 minutes.
  • the aqueous extract of seeds or sprouts is contacted with an adsorbent.
  • the aqueous extract may be separated from cellular materials and be free of seed and sprout cellular materials.
  • the aqueous extract with cellular materials may be contacted directly with adsorbents.
  • Adsorbents which may be utilized include activated carbon, silica, chemically-modified silica, bleaching clay and the like as well as and mixtures thereof.
  • the adsorbent is activated carbon.
  • about 1 to about 20 weight percent adsorbent is mixed with the aqueous extract.
  • about 8 to about 12 weight percent adsorbent is mixed with the aqueous extract.
  • the aqueous extract of seeds or sprouts is added to a column containing adsorbent materials.
  • column processing is effective for providing an extract having a ratio of alkyl glucosinolates, especially glucoraphanin to indole glucosinolates, specifically 4-hydroxyglucobrassicin, of about 30 to about 1000 or greater, preferably about 100 to about 1000.
  • food products include the chemoprotectant or chemoprotectant precursor enhanced extract.
  • the extract may be incorporated directly into food products or dried, cooled, frozen or freeze-dried and then incorporated into the food products.
  • Food product into which the extract may be incorporated include food supplements, drinks, shakes, baked goods, teas, soups, cereals, pills, tablets, salads, sandwiches, granolas, salad dressings, sauces, coffee, cheeses, yogurts, energy bars and the like as well as mixtures thereof.
  • the food product may contain an amount of extract effective for providing the food product with 0.003 weight percent to 0.05 weight percent glucoraphanin.
  • FIG. 1 provides a general description of methods for extracting chemoprotectant compounds from crucifer seeds or sprouts.
  • crucifer seeds and/or sprouts may be processed in a number of different ways.
  • An aqueous extract of the seeds or sprouts may be formed and then mixed with adsorbents or applied to an adsorbent-containing column.
  • the seeds or sprouts may be mixed directly with an aqueous extract and adsorbents. Seeds or sprouts may extracted with blending, homogenizing or pulverizing using known methods.
  • chemoprotectants and “chemoprotective compounds” refers to agents of plant origin that are effective for reducing the susceptibility of mammals to the toxic and neoplastic effects of carcinogens.
  • Chemoprotectant “precursors” refer to agents which give rise to chemoprotectants by enzymatic and/or chemical means. Talalay, P. et al, J. Nutr 2001, 131 (11 Suppl), 30275-30335. Examples of such chemoprotectant precursors include alkyl glucosinolates, such as glucoraphanin.
  • aqueous extract means extracts prepared with 100% water or up to 25% addition of an organic solvent, such as ethyl alcohol.
  • chemoprotectant precursor enhanced extract may be ultrafiltered through >500 MWCO (molecular weight cut-off) filters.
  • Crucifer seed and sprouts are useful starting materials.
  • the ratio of glucoraphanin to indole glucosinolates is naturally higher in seeds (average of ⁇ 4, with a range of 0.4 to 11) than vegetative tissue. Seeds and sprouts are preferred as a starting material since they have higher amounts of glucoraphanin as compared to mature plants. Seed and sprouts are easier to process and less expensive than mature plants.
  • Sprouts suitable as sources of cancer chemoprotectants are generally cruciferous sprouts (family Brassicaceae).
  • the sprouts are Brassica oleracea ssp. selected from the group of varieties consisting of acephala (kale, collard, wild cabbage, curly kale), medullosa (marrowstem kale) ramose (thousand head kale), alboglabra (Chinese kale), botrytis (cauliflower, sprouting broccoli), costata (Portuguese kale), gemmifera (Brussels sprouts), gogylodes (kohlrabi), italica (broccoli), palmifolia (Jersey kale), sabauda (savoy cabbage), sabellica (collards), and selensia (borecole), among others.
  • Sprouts may be prepared in commercial sprouters, providing water (misting 6 times/day) and light (10 hours/day) over a 5-day period.
  • Particularly useful broccoli cultivars to be used in the claimed method are Saga, DeCicco, Everest, Emerald City, Packman, Corvet, Dandy, Early, Emperor, Mariner, Green Comet, Green Valiant, Arcadia, Calabrese Caravel, Chancellor, Citation, Cruiser, Early Purple Sprouting Red Arrow, Eureka, Excelsior, Galleon, Ginga, Goliath, Green Duke, Greenblet, Italian Sprouting, Late Purple Sprouting, Late Winter Sprouting, White Star, Legend, Leprechaun, Marathon, Mariner, Minaret (Romanesco), Paragon, Patriot, Premium Crop, Rapine (Spring Raab), Rosalind, Salade (Fall Raab), Samurai, Shogun, Sprinter, Sultan, Taiko, Trixie, San Miguel, Arcadia, Gypsy, Everest, Patron, Southern Comet, Green Comet, Destiny, Climax and Pirate.
  • many other broccoli cultivars are suitable.
  • adsorbents refer to compounds that are effective for preferentially adsorbing indole glucosinolates over alkyl glucosinolates.
  • Useful adsorbents include activated carbon, including Norit A and Darco 12-20 mesh granular.
  • Additonal adsorbents demonstrating some effectiveness include silica, chemically-modified silica (so called C-18 loaded), and bleaching clay (used routinely in vegetable oil processing).
  • Adsorbents found ineffective included alumina (neutral, acidic and basic) and Fuller's earth (montmorillonite).
  • Chemoprotectant precursor enhanced extracts of crucifers seeds may be incorporated into a variety of foodstuffs.
  • the extract may be dried, cooled, frozen or freeze-dried using known methods.
  • extracts may be further processed, for example with membrane-processing or dialysis to remove high molecular weight compounds such as proteins and polysaccharides.
  • a 30 ml sample of aqueous extract from 1 g of pulverized defatted broccoli seed (var. Gypsy) was treated with 100 mg of activated carbon (Darco G-60) 12-20 mesh by boiling for 1 min. in 30 ml of water followed by filtration to remove spent adsorbent and provide an aqueous extract.
  • the initial ratio of glucoraphanin/4-hydroxglucobrassicin of ⁇ 11 in the initial seed was increased to ⁇ 70 in the treated matter. Loss of glucoraphanin was ⁇ 4% as determined by high performance liquid chromatography (HPLC), West, L. et al., J. Chromatogr. A 2002, 966, 227-232.
  • a 30 ml sample of aqueous extract from 1 g of pulverized defatted broccoli seed (var Gypsy) was passed down a column containing 1000 mg of graphitized carbon black.
  • the initial ratio of glucoraphanin/4-hydroxyglucobrassicin of ⁇ 11 in the initial seed was increased to >1000.
  • Loss of glucoraphanin was ⁇ 13% as determined by HPLC.
  • a 100 mg portion of activated carbon (Darco G-60) was admixed with 1 g of pulverized defatted broccoli seed (var. Gypsy) and extracted in boiling water followed by centrifugation to remove particulates.
  • the initial ratio of glucoraphanin/4-hydroxyglucobrassicin of ⁇ 11 was increased to ⁇ 30. Loss of glucoraphanin was ⁇ 2% as determined by HPLC.
  • a 200 g. portion of pulverized and defatted (hexane extractable lipids) broccoli seed (var. Premium Crop) was added to 2 L of boiling water. After 5 min. at boiling water temperature, the mixture was filtered to remove residual plant material and the aqueous extract was treated with 20 g. of activated carbon (Darco G-60) by boiling for ⁇ 1 min. followed by centrifugation and filtration to remove spent adsorbent. The clarified extract was ultrafiltered using a 3000 MWCO membrane all the while retaining the ultrafiltrate. After drying, the light tan in color powder was analyzed by HPLC and found to contain over 30% glucoraphanin by weight and a glucoraphanin/4-hydroxyglucobrassicin ratio of greater than 1000.
  • activated carbon Darco G-60
  • a 500 g. sample of ⁇ 5 day old whole fresh broccoli sprouts (sprouted from var. Premium Crop) were added to 2 L of boiling water. After 10 min. at boiling water temperature, the mixture was transferred to a blender operating at high speed to disrupt the plant tissue for the purpose of further releasing glucoraphanin. After filtration to remove the residual plant material, the aqueous extract was treated with 20 g. of activated carbon (Darco G-60) by boiling for ⁇ 1 min. followed by centrifugation and filtration to remove spent adsorbent. The clarified extract was ultrafiltered using a 3000 MWCO membrane all the while retaining the ultrafiltrate. After drying, the white in color powder was analyzed by HPLC and found to contain over 10% glucoraphanin by weight and a glucoraphanin/4-hydroxyglucobrassicin ratio of greater than 1000.
  • activated carbon Darco G-60

Abstract

The present invention is directed to chemoprotectant precursor compositions provided from crucifer seeds and sprouts and methods for their preparation. Treatment of aqueous extracts from crucifer seeds or sprouts with adsorbents substantially increases the ratio of certain highly chemoprotectant precursor compounds (alkyl glucosinolates such as glucoraphanin, a.k.a. sulforaphane glucosinolate) to undesirable compounds such as indole glucosinolates (for example 4-hydroxyglucobrassicin). The method provides an extract which has a ratio of glucoraphanin to 4-hydroxyglucobrassicin of about 70 or greater. The resulting extract has improved color and odor and may be dried or used directly as an additive in a variety of foodstuffs.

Description

  • The present invention relates to chemoprotective compounds and method for producing chemoprotective compounds which may be incorporated into a variety of food products. More specifically, an extraction method is provided that is effective for providing an extract having a high ratio of chemoprotective compounds to less desirable compounds while providing a high yield of chemoprotective compounds. Enhanced yields and ratios of chemoprotective compounds are provided by an aqueous extraction method used in combination with adsorbents.
  • BACKGROUND
  • It is generally agreed that diet plays a large role in controlling the risk of developing cancers and that increased consumption of fruits and vegetables may reduce cancer incidences in humans. The presence of certain minor chemical components in plants may provide a major protection mechanism when delivered to mammalian cells.
  • Cruciferious vegetables contain phytochemical precursors to potent chemoprotectants especially glucoraphanin and its associated conversion product sulforaphane, that when delivered to mammalian cells trigger carcinogen detoxification mechanisms. In addition to reducing the risk of getting certain cancers, glucoraphanin through its bioactive conversion product sulforphane has recently been shown effective in destroying the organism responsible for causing the majority of stomach ulcers and may provide novel approaches for reducing the risk of developing cardiovascular and ocular diseases. Efforts are being undertaken to gain approval for making label claims on food products either naturally high in these agents or for foods containing added crucifer chemoprotectants. Products containing chemoprotectant additives, although without claims, are already on the market.
  • Cruciferous vegetables also contain other compounds, such as indole glucosinolates, which are problematic for maintaining good health. Not only are these compounds weak inducers of the carcinogen detoxification system, but also they can induce systems which may bioactivate certain pro-carcinogens. In addition, the breakdown products of indole glucosinolates formed in the stomach during digestion may act in a similar manner to dioxin, a very potent toxin. Therefore, it is advantageous to produce glucoraphanin-containing preparations containing as little residual indole glucosinolates, or other adverse compounds, as possible.
  • Several patents describe the development of highly chemoprotecant crucifer germplasm with a significantly improved ratio of glucoraphanin to indole glucosinolates (increasing the ratio from about 0.2 to ˜30). See, e.g., U.S. Pat. Nos. 6,521,818, 6,242,018, 6,177,122, 5,968,567, 5,968,505 and 5,725,895; however, developing the germplasm from laboratory to field trials to market will require considerable time, upwards of up to 5 years, and with no guarantee of success. Hence, there is a need to provide alternative methods for producing high yields of glucoraphanin with a high ratio of glucoraphanin to indole glucosinolates.
  • SUMMARY
  • The present invention is directed to chemoprotectant precursor compositions provided from crucifer seeds and sprouts and methods for their preparation. Treatment of aqueous extracts from crucifer seeds or sprouts with adsorbents substantially increases the ratio of certain highly chemoprotectant precursor compounds (alkyl glucosinolates such as glucoraphanin, a.k.a. sulforaphane glucosinolate) to undesirable compounds such as indole glucosinolates (for example 4-hydroxyglucobrassicin). The method provides an extract which has a ratio of glucoraphanin to 4-hydroxyglucobrassicin of about 70 or greater. The resulting extract has improved color and odor and may be dried or used directly as an additive in a variety of foodstuffs.
  • A method is provided for extracting chemoprotectants precursors from crucifer seeds or sprouts. Generally, the method includes forming an aqueous extract of crucifer seeds or sprouts. The aqueous extract is contacted with an adsorbent. The aqueous extract is separated from the adsorbent to provide a chemoprotectant enhanced extract. The method is effective for providing a chemoprotectant enhanced extract having a ratio of a number of alkyl glucosinolates, especially glucoraphanin to indole glucosinolates, specifically 4-hydroxyglucobrassicin of about 30 to about 1000 or greater, preferably about 100 to about 1000.
  • Crucifer vegetables have been identified as a good source of chemoprotectant precursor phytochemicals. Crucifer seeds and sprouts have been found to be an especially good source of chemoprotectant precursors. Crucifer seeds or sprouts which are especially useful include broccoli, kale, collard, curly kale, marrowstem kale, thousand head kale, Chinese kale, cauliflower, Portuguese kale, Brussels sprouts, kohlrabi, Jersey kale, savoy cabbage, collards, borecole, radish, and the like as well as mixtures thereof. In a very important aspect, crucifier seeds or seeds and sprouts of broccoli are utilized.
  • When crucifer seeds are used as a starting material, they may be used directly or may be processed prior to aqueous extraction. In one aspect, crucifer seeds may be defatted prior to forming an aqueous extract using known defatting procedures. For example, West, L. et al., J Agric. Food Chem. 2004, 52, 916-926, which is incorporated herein by reference. In another aspect, crucifer seeds may be ground, pulverized or blended prior to addition of aqueous extract or simultaneously with the addition of an aqueous extract.
  • Extraction of seed or sprouts may be conducted with water or water containing an organic solvent, such as ethyl alcohol. In another alternative aspect, an aqueous extract of crucifer seeds or sprouts is formed by contacting crucifer seeds or sprouts with water having a temperature of 60 to 110° C. for at least 5 minutes.
  • The aqueous extract of seeds or sprouts is contacted with an adsorbent. The aqueous extract may be separated from cellular materials and be free of seed and sprout cellular materials. Alternatively, the aqueous extract with cellular materials may be contacted directly with adsorbents. Adsorbents which may be utilized include activated carbon, silica, chemically-modified silica, bleaching clay and the like as well as and mixtures thereof. In a very important aspect, the adsorbent is activated carbon. Generally, about 1 to about 20 weight percent adsorbent is mixed with the aqueous extract. In a very important aspect, about 8 to about 12 weight percent adsorbent is mixed with the aqueous extract.
  • In another aspect, the aqueous extract of seeds or sprouts is added to a column containing adsorbent materials. In this aspect, column processing is effective for providing an extract having a ratio of alkyl glucosinolates, especially glucoraphanin to indole glucosinolates, specifically 4-hydroxyglucobrassicin, of about 30 to about 1000 or greater, preferably about 100 to about 1000.
  • In another aspect, food products are provided that include the chemoprotectant or chemoprotectant precursor enhanced extract. The extract may be incorporated directly into food products or dried, cooled, frozen or freeze-dried and then incorporated into the food products. Food product into which the extract may be incorporated include food supplements, drinks, shakes, baked goods, teas, soups, cereals, pills, tablets, salads, sandwiches, granolas, salad dressings, sauces, coffee, cheeses, yogurts, energy bars and the like as well as mixtures thereof. In this aspect, the food product may contain an amount of extract effective for providing the food product with 0.003 weight percent to 0.05 weight percent glucoraphanin.
  • BRIEF DESCRIPTION OF THE FIGURE
  • FIG. 1 provides a general description of methods for extracting chemoprotectant compounds from crucifer seeds or sprouts.
  • DETAILED DESCRIPTION
  • As shown in FIG. 1, crucifer seeds and/or sprouts may be processed in a number of different ways. An aqueous extract of the seeds or sprouts may be formed and then mixed with adsorbents or applied to an adsorbent-containing column. Alternatively, the seeds or sprouts may be mixed directly with an aqueous extract and adsorbents. Seeds or sprouts may extracted with blending, homogenizing or pulverizing using known methods.
  • As used herein “chemoprotectants” and “chemoprotective compounds” refers to agents of plant origin that are effective for reducing the susceptibility of mammals to the toxic and neoplastic effects of carcinogens. Chemoprotectant “precursors” refer to agents which give rise to chemoprotectants by enzymatic and/or chemical means. Talalay, P. et al, J. Nutr 2001, 131 (11 Suppl), 30275-30335. Examples of such chemoprotectant precursors include alkyl glucosinolates, such as glucoraphanin.
  • As used herein “aqueous extract” means extracts prepared with 100% water or up to 25% addition of an organic solvent, such as ethyl alcohol.
  • Other methods which may be used to selectively concentrate chemoprotectants and chemoprotectant precursors include: preparative liquid chromatography, membrane ultrafiltration, selective precipitation, preparative electrophoresis and preparative counter current distribution techniques. Troyer, J. et al., J. Chromatogr. A 2001, 919, 299-304; West, L. et al. J. Chromatogr. A 2002, 966, 227-232; Fahey, J. et al. J. Chromatogr. A 2003, 966, 85-93; and Iori, R., Patent Application B098A 000425 1998. In another alternative, to further purify extracts based on molecular weight, chemoprotectant precursor enhanced extract may be ultrafiltered through >500 MWCO (molecular weight cut-off) filters.
  • Crucifer Seeds and Sprouts
  • Crucifer seed and sprouts are useful starting materials. The ratio of glucoraphanin to indole glucosinolates is naturally higher in seeds (average of ˜4, with a range of 0.4 to 11) than vegetative tissue. Seeds and sprouts are preferred as a starting material since they have higher amounts of glucoraphanin as compared to mature plants. Seed and sprouts are easier to process and less expensive than mature plants.
  • Sprouts suitable as sources of cancer chemoprotectants are generally cruciferous sprouts (family Brassicaceae). Preferably the sprouts are Brassica oleracea ssp. selected from the group of varieties consisting of acephala (kale, collard, wild cabbage, curly kale), medullosa (marrowstem kale) ramose (thousand head kale), alboglabra (Chinese kale), botrytis (cauliflower, sprouting broccoli), costata (Portuguese kale), gemmifera (Brussels sprouts), gogylodes (kohlrabi), italica (broccoli), palmifolia (Jersey kale), sabauda (savoy cabbage), sabellica (collards), and selensia (borecole), among others. Numerous methods for the cultivation of sprouts are known, as exemplified by U.S. Pat. Nos. 3,733,745, 3,643,376, 3,945,148, 4,130,964, 4,292,769 and 4,086,725 which are all incorporated herein by reference. Sprouts may be prepared in commercial sprouters, providing water (misting 6 times/day) and light (10 hours/day) over a 5-day period.
  • Particularly useful broccoli cultivars to be used in the claimed method are Saga, DeCicco, Everest, Emerald City, Packman, Corvet, Dandy, Early, Emperor, Mariner, Green Comet, Green Valiant, Arcadia, Calabrese Caravel, Chancellor, Citation, Cruiser, Early Purple Sprouting Red Arrow, Eureka, Excelsior, Galleon, Ginga, Goliath, Green Duke, Greenblet, Italian Sprouting, Late Purple Sprouting, Late Winter Sprouting, White Star, Legend, Leprechaun, Marathon, Mariner, Minaret (Romanesco), Paragon, Patriot, Premium Crop, Rapine (Spring Raab), Rosalind, Salade (Fall Raab), Samurai, Shogun, Sprinter, Sultan, Taiko, Trixie, San Miguel, Arcadia, Gypsy, Everest, Patron, Southern Comet, Green Comet, Destiny, Climax and Pirate. However, many other broccoli cultivars are suitable.
  • Adsorbents
  • Crucifers seed or sprouts or aqueous extracts of crucifer seed or sprouts may be mixed directly with adsorbents in batch mode, semi-continuous mode or continuous mode (e.g. using an adsorbent column). As used herein, adsorbents refer to compounds that are effective for preferentially adsorbing indole glucosinolates over alkyl glucosinolates. Useful adsorbents include activated carbon, including Norit A and Darco 12-20 mesh granular. Additonal adsorbents demonstrating some effectiveness include silica, chemically-modified silica (so called C-18 loaded), and bleaching clay (used routinely in vegetable oil processing). Adsorbents found ineffective included alumina (neutral, acidic and basic) and Fuller's earth (montmorillonite).
  • Processing of Extracts
  • Chemoprotectant precursor enhanced extracts of crucifers seeds may be incorporated into a variety of foodstuffs. The extract may be dried, cooled, frozen or freeze-dried using known methods. Alternatively, extracts may be further processed, for example with membrane-processing or dialysis to remove high molecular weight compounds such as proteins and polysaccharides.
  • EXAMPLES Example 1 Batch Processing of Broccoli Seeds
  • A 30 ml sample of aqueous extract from 1 g of pulverized defatted broccoli seed (var. Gypsy) was treated with 100 mg of activated carbon (Darco G-60) 12-20 mesh by boiling for 1 min. in 30 ml of water followed by filtration to remove spent adsorbent and provide an aqueous extract. The initial ratio of glucoraphanin/4-hydroxglucobrassicin of ˜11 in the initial seed was increased to ˜70 in the treated matter. Loss of glucoraphanin was ˜4% as determined by high performance liquid chromatography (HPLC), West, L. et al., J. Chromatogr. A 2002, 966, 227-232.
  • Example 2 Column Processing of Broccoli Seeds
  • A 30 ml sample of aqueous extract from 1 g of pulverized defatted broccoli seed (var Gypsy) was passed down a column containing 1000 mg of graphitized carbon black. The initial ratio of glucoraphanin/4-hydroxyglucobrassicin of ˜11 in the initial seed was increased to >1000. Loss of glucoraphanin was ˜13% as determined by HPLC.
  • Example 3 Boiling Water Processing of Broccoli Seeds
  • A 100 mg portion of activated carbon (Darco G-60) was admixed with 1 g of pulverized defatted broccoli seed (var. Gypsy) and extracted in boiling water followed by centrifugation to remove particulates. The initial ratio of glucoraphanin/4-hydroxyglucobrassicin of ˜11 was increased to ˜30. Loss of glucoraphanin was ˜2% as determined by HPLC.
  • Example 4 Processing of Broccoli Seeds with Ultrafiltration
  • A 200 g. portion of pulverized and defatted (hexane extractable lipids) broccoli seed (var. Premium Crop) was added to 2 L of boiling water. After 5 min. at boiling water temperature, the mixture was filtered to remove residual plant material and the aqueous extract was treated with 20 g. of activated carbon (Darco G-60) by boiling for ˜1 min. followed by centrifugation and filtration to remove spent adsorbent. The clarified extract was ultrafiltered using a 3000 MWCO membrane all the while retaining the ultrafiltrate. After drying, the light tan in color powder was analyzed by HPLC and found to contain over 30% glucoraphanin by weight and a glucoraphanin/4-hydroxyglucobrassicin ratio of greater than 1000.
  • Example 5 Processing of Broccoli Sprouts with Blending and Ultrafiltration
  • A 500 g. sample of ˜5 day old whole fresh broccoli sprouts (sprouted from var. Premium Crop) were added to 2 L of boiling water. After 10 min. at boiling water temperature, the mixture was transferred to a blender operating at high speed to disrupt the plant tissue for the purpose of further releasing glucoraphanin. After filtration to remove the residual plant material, the aqueous extract was treated with 20 g. of activated carbon (Darco G-60) by boiling for ˜1 min. followed by centrifugation and filtration to remove spent adsorbent. The clarified extract was ultrafiltered using a 3000 MWCO membrane all the while retaining the ultrafiltrate. After drying, the white in color powder was analyzed by HPLC and found to contain over 10% glucoraphanin by weight and a glucoraphanin/4-hydroxyglucobrassicin ratio of greater than 1000.

Claims (19)

1-14. (canceled)
15. A chemoprotectant precursor enhanced extract containing crucifer seeds or sprouts formed by a process comprising:
forming an aqueous extract of crucifer seeds or sprouts;
contacting the aqueous extract with an adsorbent; and
separating the adsorbent from the aqueous extract to provide the chemoprotectant precursor enhanced extract,
the method effective for providing a number ratio of alkyl glucosinolates to indole glucosinolates of at least about 30 in the chemoprotectant precursor enhanced extract.
16. The method of claim 15, wherein the alkyl glucosinolates are glucoraphanin.
17. The method of claim 15, wherein the indole glucosinolates are 4-hydroxyglucobrassicin.
18. The method of claim 15, wherein the ratio of a number of alkyl glucosinolates to indole glucosinolates is about 30 to about 1000.
19. The method of claim 15, wherein the ratio of a number of alkyl glucosinolates to indole glucosinolates is about 1000 or greater.
20. The chemoprotectant precursor enhanced extract of claim 15, wherein the crucifer seeds or sprouts are selected from the group consisting of broccoli, kale, collard, curly kale, marrowstem kale, thousand head kale, Chinese kale, cauliflower, Portuguese kale, Brussels sprouts, kohlrabi, Jersey kale, savoy cabbage, collards, borecole, radish and mixtures thereof.
21. The chemoprotectant precursor enhanced extract of claim 20, wherein the crucifer seeds or sprouts are broccoli.
22. The chemoprotectant precursor enhanced extract of claim 20, wherein the crucifer seeds are defatted prior to forming an aqueous extract.
23. The chemoprotectant precursor enhanced extract of claim 15, wherein the aqueous extract of crucifer seeds or sprouts is formed by contacting crucifer seeds or sprouts with water having a temperature of about 60° to about 110° C. for at least about 5 minutes.
24. The chemoprotectant precursor enhanced extract of claim 15, wherein the adsorbent is selected from the group consisting of activated carbon, silica, chemically-modified silica, bleaching clay, and mixtures thereof.
25. The chemoprotectant precursor enhanced extract of claim 24, wherein the adsorbent is activated carbon.
26. The chemoprotectant precursor enhanced extract of claim 15, wherein about 1 to about 20 weight percent adsorbent is mixed with the aqueous extract.
27. The chemoprotectant precursor enhanced extract of claim 25, wherein about 8 to about 12 weight percent adsorbent is mixed with the aqueous extract.
28. The chemoprotectant precursor enhanced extract of claim 15, wherein the aqueous extract is added to a column containing adsorbent.
29. The chemoprotectant precursor enhanced extract of claim 15, wherein the aqueous extract is dried, cooled, frozen or freeze-dried.
30. The chemoprotectant precursor enhanced extract of claim 15, wherein the aqueous extract is ultrafiltered through at least a 500 MWCO membranes.
31. A food product comprising an effective amount of the extract of claim 1.
32. The food product of claim 31, wherein the food product is selected from the group consisting of food supplements, drinks, shakes, baked goods, teas, soups, cereals, pills, tablets, salads, sandwiches, granolas, salad dressings, sauces, coffee, cheeses, yogurts, energy bars and mixtures thereof.
US12/687,490 2005-08-09 2010-01-14 Chemoprotectants From Crucifer Seeds And Sprouts Abandoned US20100124598A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/687,490 US20100124598A1 (en) 2005-08-09 2010-01-14 Chemoprotectants From Crucifer Seeds And Sprouts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/199,752 US7744937B2 (en) 2005-08-09 2005-08-09 Chemoprotectants from crucifer seeds and sprouts
US12/687,490 US20100124598A1 (en) 2005-08-09 2010-01-14 Chemoprotectants From Crucifer Seeds And Sprouts

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/199,752 Division US7744937B2 (en) 2005-08-09 2005-08-09 Chemoprotectants from crucifer seeds and sprouts

Publications (1)

Publication Number Publication Date
US20100124598A1 true US20100124598A1 (en) 2010-05-20

Family

ID=37523538

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/199,752 Expired - Fee Related US7744937B2 (en) 2005-08-09 2005-08-09 Chemoprotectants from crucifer seeds and sprouts
US12/687,490 Abandoned US20100124598A1 (en) 2005-08-09 2010-01-14 Chemoprotectants From Crucifer Seeds And Sprouts

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/199,752 Expired - Fee Related US7744937B2 (en) 2005-08-09 2005-08-09 Chemoprotectants from crucifer seeds and sprouts

Country Status (12)

Country Link
US (2) US7744937B2 (en)
EP (1) EP1752052B1 (en)
CN (1) CN1935003A (en)
AR (1) AR054902A1 (en)
AU (1) AU2006203321B2 (en)
BR (1) BRPI0603903A (en)
CA (1) CA2554969A1 (en)
NO (1) NO20063553L (en)
NZ (1) NZ548951A (en)
PL (1) PL1752052T3 (en)
RU (1) RU2378002C2 (en)
UA (1) UA92140C2 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105198782A (en) * 2015-10-23 2015-12-30 河南科技学院 Method for extracting, separating and purifying sulforaphene in radish seeds
CN105713053A (en) * 2016-03-26 2016-06-29 北京化工大学 Extraction and separation method of glucosinolate
US9585860B2 (en) 2011-01-12 2017-03-07 The William M. Yavbrough Foundation Method for treating eczema
US9636320B2 (en) 2012-07-26 2017-05-02 The William M. Yarbrough Foundation Method for treating skin cancer
US9771322B2 (en) 2011-01-03 2017-09-26 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10532039B2 (en) 2011-02-08 2020-01-14 The William M. Yarbrough Foundation Method for treating psoriasis
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7744937B2 (en) 2005-08-09 2010-06-29 Kraft Foods Global Brands Llc Chemoprotectants from crucifer seeds and sprouts
US7371419B1 (en) * 2006-12-29 2008-05-13 Kraft Foods Holdings, Inc. Method of enriching glucoraphanin in radish seed preparations
US20080311192A1 (en) * 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Enteric-Coated Glucosinolates And Beta-Thioglucosidases
US20080311276A1 (en) * 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Production of Glucosinolates from Agricultural By-Products & Waste
IT1394763B1 (en) * 2009-06-19 2012-07-13 Bios Line S P A METHOD OF PREPARATION OF PURIFIED EXTRACT FROM CABBAGE LACINIATO NERO TOSCANO AND COMPOSITIONS OF THE SAME
CN102399247B (en) * 2010-09-19 2013-10-02 上海中医药大学 Method for separating potassium myronate compounds from indigowoad root
WO2012116018A1 (en) 2011-02-22 2012-08-30 Caudill Seed Company, Inc. Spray dried myrosinase and use to produce isothiocyanates
FR2977161B1 (en) * 2011-07-01 2013-07-19 Sojasun Technologies COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PROSTATE CANCER BASED ON BROCOLI SEED EXTRACT.
CN104803900B (en) * 2015-04-29 2016-08-24 重庆大学 A kind of method preparing sulforaphen continuously
CN104800270B (en) * 2015-05-20 2018-07-31 皖南医学院 A kind of preparation method of broccoli sprout extract capsule
CN107710962A (en) * 2017-11-16 2018-02-23 蚌埠市徽吉星农业科技农民专业合作社 A kind of sponge gourd method for treating seeds
CN108702891A (en) * 2018-04-11 2018-10-26 上海大学 Application of the carbon monoxide in handling vegetable seeds
TWI693072B (en) * 2018-12-14 2020-05-11 大漢酵素生物科技股份有限公司 Anti-cancer fermented liquid with glucosinolate compound and usage thereof
CN113180097A (en) * 2021-04-27 2021-07-30 成都市三禾田生物技术有限公司 Production method of lyophilized broccoli sprout powder

Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083836A (en) * 1974-05-17 1978-04-11 Alfa-Laval Ab Production of rapeseed protein concentrate for human consumption
US5043178A (en) * 1988-02-09 1991-08-27 Kraft General Foods, Inc. Method for the extraction of roasted and ground coffee
US5077071A (en) * 1989-09-06 1991-12-31 Epe Incorporated Oil extrusion process
US5686108A (en) * 1995-09-27 1997-11-11 Amway Corporation Brassica vegetable supplement and process for manufacture
US5725895A (en) * 1995-09-15 1998-03-10 Johns Hopkins School Of Medicine Method of preparing a food product from cruciferous seeds
US6086936A (en) * 1995-12-14 2000-07-11 Kal Kan Foods, Inc. High temperature/ultra-high pressure sterilization of foods
US6117460A (en) * 1996-12-16 2000-09-12 Kortschack; Fritz Method of producing stable meat products and sausages, produced in the presence of microorganisms
US6242018B1 (en) * 1997-04-11 2001-06-05 Johns Hopkins School Of Medicine Cancer Chemoprotective food products
US20020015722A1 (en) * 1999-05-05 2002-02-07 Herzog Leslie John Food product
US6348220B1 (en) * 1999-04-09 2002-02-19 Rutgers, The State University Of New Jersey Phenethylisothiocyanate nutraceutical compositions and methods
US6361812B1 (en) * 1999-11-18 2002-03-26 The Procter & Gamble Co. Products comprising an isothiocyanate preservative system and methods of their use
US20020090405A1 (en) * 2000-09-15 2002-07-11 Najla Guthrie Components of canola for the treatment of cancer
US6436450B1 (en) * 2000-12-08 2002-08-20 Access Business Group International Llc Brassica vegetable composition and method for manufacture of same
US20020147155A1 (en) * 2001-04-06 2002-10-10 Foster Warren G. Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
US20020151505A1 (en) * 2000-08-21 2002-10-17 Fahey Jed W. Treatment of helicobacter with isothiocyanates
US6521818B1 (en) * 1998-07-01 2003-02-18 John Hopkins School Of Medicine Development of novel highly chemoprotectant crucifer germplasm
US20030091518A1 (en) * 1999-12-20 2003-05-15 Gilles Pauly Cosmetic and/or pharmaceutical preparations
US20030235634A1 (en) * 2002-06-21 2003-12-25 Access Business Group International Llc. Extraction of non-polar isothiocyanates from plants and dietary supplements containing same
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20040052879A1 (en) * 2000-05-30 2004-03-18 Giampietro Ravagnan Method for the extraction of pharmaceutically active products from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with anti-tumoral activity
US20040133936A1 (en) * 2000-08-17 2004-07-08 John Rossiter Enzyme
US6812248B2 (en) * 2000-07-05 2004-11-02 John Hopkins University School Of Medicine Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes
US20050031768A1 (en) * 2003-08-07 2005-02-10 Shiro Sakai Fractionation of allyl isothiocyanate, p-hydroxybenzyl-isothiocyanate, protein and fiber from mustard
US20050042347A1 (en) * 2002-01-28 2005-02-24 Bathurst Christopher Francis Composition
US20050055744A1 (en) * 2001-07-05 2005-03-10 Carlos Quiros Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use
US20050123560A1 (en) * 2003-12-04 2005-06-09 Sinnott Robert A. High purity and water dispersible extract and formulations of larrea tridentata leaf resin, and methods of making and using the same
US20060003073A1 (en) * 2004-05-07 2006-01-05 Etzel Mark R Methods and compositions involving whey protein isolates
US20060020046A1 (en) * 2002-02-15 2006-01-26 Dms Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
US20060127996A1 (en) * 2004-12-14 2006-06-15 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolate-containing plants and method of producing products with oil containing isothiocyanates extracted from glucosinolate-containing plants
US20070033675A1 (en) * 2003-04-14 2007-02-08 Piet Barten Brassica plants with high levels of anticarcinogenic glucosinolates
US20070031581A1 (en) * 2005-08-09 2007-02-08 Kraft Foods Holdings, Inc. Chemoprotectants from crucifer seeds and sprouts
US20070190209A1 (en) * 2006-02-10 2007-08-16 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
US20080107792A1 (en) * 2003-07-31 2008-05-08 Martine Elisa Verhoeyen Use of Plants with Increased Levels of Flavonol Glycosides in Reducing Hypertension
US7371419B1 (en) * 2006-12-29 2008-05-13 Kraft Foods Holdings, Inc. Method of enriching glucoraphanin in radish seed preparations
US7407986B2 (en) * 2001-12-18 2008-08-05 Brassica Foundation For Chemoprotection Research, Inc. Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3945148A (en) 1975-03-10 1976-03-23 George Clem Oyama Method and apparatus for growing bean sprouts
US4130964A (en) 1975-12-01 1978-12-26 Caballero Edward A Apparatus and method for growing legume sprouts
US4086725A (en) 1976-06-25 1978-05-02 Tsiang Kwang Li Method and apparatus for growing plant sprouts
CH622346A5 (en) 1977-09-29 1981-03-31 Kistler Instrumente Ag
EP0006654B1 (en) 1978-06-26 1982-03-31 Unilever N.V. A process for producing a detoxified rapeseed protein concentrate
CA2172244A1 (en) 1993-09-24 1995-03-30 Johannes Petrus Paulus Maria Smelt Shelf stable product
DE69430619D1 (en) 1994-02-17 2002-06-20 Nestle Sa Production of low-salt and / or low-phosphate sausages
DE19649952A1 (en) 1996-12-03 1998-06-04 Uhde Hochdrucktechnik Gmbh Process for the preservation of solid, liquid or pasty perishable products
GB9717104D0 (en) 1997-08-12 1997-10-15 Innes John Centre Innov Ltd Food products
FR2769837B1 (en) 1997-10-17 2000-02-25 Bio Sphere 99 Lab COMPOSITION FOR DIETETICS OR COSMETICS BASED ON PLANT EXTRACTS
US20030161917A1 (en) 1998-01-20 2003-08-28 Ernest A. Voisin Process of elimination of bacteria in shellfish of shucking shellfish and an apparatus therefor
FR2786096B1 (en) 1998-11-20 2002-10-18 Jean Pascal Conduzorgues COMPOSITION FOR THE PREVENTION AND TOPICAL TREATMENT OF CELLULITE
IT1317034B1 (en) 2000-05-30 2003-05-26 Istituto Di Medicina Speriment METHOD OF EXTRACTION OF PHARMACEUTICAL ACTIVITY PRODUCTS FROM PLANTS SPERMATOPHYTES, PRODUCTS SO OBTAINED AND THEIR USE IN MEDICINE, IN
FI116878B (en) 2003-02-21 2006-03-31 Maa Ja Elintarviketalouden Tut Control of the enzymatic degradation of glucosinolates by the lactic acid bacterium
JP2005206495A (en) 2004-01-21 2005-08-04 Univ Nihon Health food for preventing cancer and medicinal composition
WO2006012213A2 (en) 2004-06-25 2006-02-02 Tea Guard Llc Composition and method for delivery of phytochemicals
WO2006102236A1 (en) 2005-03-18 2006-09-28 Caudill Seed Inc. Cancer chemoprotective compositions and natural oils and methods for making same
DE102005033616A1 (en) 2005-07-19 2007-01-25 Biopro Ag Biological Products Production of Brassica extracts with high anti-cancer sulforaphane content involves degradation of plant material in presence of myrosinase enzyme and glucosinolate

Patent Citations (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083836A (en) * 1974-05-17 1978-04-11 Alfa-Laval Ab Production of rapeseed protein concentrate for human consumption
US5043178A (en) * 1988-02-09 1991-08-27 Kraft General Foods, Inc. Method for the extraction of roasted and ground coffee
US5077071A (en) * 1989-09-06 1991-12-31 Epe Incorporated Oil extrusion process
US5725895B1 (en) * 1995-09-15 2000-10-10 Hopkins J School Of Medicine Method of preparing food product from cruciferous seeds
US5725895A (en) * 1995-09-15 1998-03-10 Johns Hopkins School Of Medicine Method of preparing a food product from cruciferous seeds
US5968567A (en) * 1995-09-15 1999-10-19 John Hopkins School Of Medicine Method of preparing a food product from cruciferous sprouts
US5968505A (en) * 1995-09-15 1999-10-19 Johns Hopkins School Of Medicine Cancer chemoprotective food products
US6177122B1 (en) * 1995-09-15 2001-01-23 Johns Hopkins School Of Medicine Cancer chemoprotective food products
US5686108A (en) * 1995-09-27 1997-11-11 Amway Corporation Brassica vegetable supplement and process for manufacture
US5882646A (en) * 1995-09-27 1999-03-16 Amway Corporation Brassica vegetable supplement and process for manufacture
US6086936A (en) * 1995-12-14 2000-07-11 Kal Kan Foods, Inc. High temperature/ultra-high pressure sterilization of foods
US6117460A (en) * 1996-12-16 2000-09-12 Kortschack; Fritz Method of producing stable meat products and sausages, produced in the presence of microorganisms
US6242018B1 (en) * 1997-04-11 2001-06-05 Johns Hopkins School Of Medicine Cancer Chemoprotective food products
US7303770B2 (en) * 1997-04-11 2007-12-04 Johns Hopkins School Of Medicine Cancer chemoprotective food products
US6521818B1 (en) * 1998-07-01 2003-02-18 John Hopkins School Of Medicine Development of novel highly chemoprotectant crucifer germplasm
US6348220B1 (en) * 1999-04-09 2002-02-19 Rutgers, The State University Of New Jersey Phenethylisothiocyanate nutraceutical compositions and methods
US20020015722A1 (en) * 1999-05-05 2002-02-07 Herzog Leslie John Food product
US6361812B1 (en) * 1999-11-18 2002-03-26 The Procter & Gamble Co. Products comprising an isothiocyanate preservative system and methods of their use
US20030091518A1 (en) * 1999-12-20 2003-05-15 Gilles Pauly Cosmetic and/or pharmaceutical preparations
US20040052879A1 (en) * 2000-05-30 2004-03-18 Giampietro Ravagnan Method for the extraction of pharmaceutically active products from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with anti-tumoral activity
US6812248B2 (en) * 2000-07-05 2004-11-02 John Hopkins University School Of Medicine Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes
US20040133936A1 (en) * 2000-08-17 2004-07-08 John Rossiter Enzyme
US7402569B2 (en) * 2000-08-21 2008-07-22 Brassica Foundation For Chemoprotection Research, Inc. Treatment of Helicobacter with isothiocyanates
US6737441B2 (en) * 2000-08-21 2004-05-18 Jed W. Fahey Treatment of helicobacter with isothiocyanates
US20020151505A1 (en) * 2000-08-21 2002-10-17 Fahey Jed W. Treatment of helicobacter with isothiocyanates
US20020090405A1 (en) * 2000-09-15 2002-07-11 Najla Guthrie Components of canola for the treatment of cancer
US6436450B1 (en) * 2000-12-08 2002-08-20 Access Business Group International Llc Brassica vegetable composition and method for manufacture of same
US20020147155A1 (en) * 2001-04-06 2002-10-10 Foster Warren G. Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
US20050055744A1 (en) * 2001-07-05 2005-03-10 Carlos Quiros Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use
US7407986B2 (en) * 2001-12-18 2008-08-05 Brassica Foundation For Chemoprotection Research, Inc. Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
US20050042347A1 (en) * 2002-01-28 2005-02-24 Bathurst Christopher Francis Composition
US20060020046A1 (en) * 2002-02-15 2006-01-26 Dms Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20030235634A1 (en) * 2002-06-21 2003-12-25 Access Business Group International Llc. Extraction of non-polar isothiocyanates from plants and dietary supplements containing same
US6824796B2 (en) * 2002-06-21 2004-11-30 Access Business Group International Llc Extraction of non-polar isothiocyanates from plants
US20070033675A1 (en) * 2003-04-14 2007-02-08 Piet Barten Brassica plants with high levels of anticarcinogenic glucosinolates
US20080107792A1 (en) * 2003-07-31 2008-05-08 Martine Elisa Verhoeyen Use of Plants with Increased Levels of Flavonol Glycosides in Reducing Hypertension
US20050031768A1 (en) * 2003-08-07 2005-02-10 Shiro Sakai Fractionation of allyl isothiocyanate, p-hydroxybenzyl-isothiocyanate, protein and fiber from mustard
US20050123560A1 (en) * 2003-12-04 2005-06-09 Sinnott Robert A. High purity and water dispersible extract and formulations of larrea tridentata leaf resin, and methods of making and using the same
US20060003073A1 (en) * 2004-05-07 2006-01-05 Etzel Mark R Methods and compositions involving whey protein isolates
US20060127996A1 (en) * 2004-12-14 2006-06-15 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolate-containing plants and method of producing products with oil containing isothiocyanates extracted from glucosinolate-containing plants
US20070031581A1 (en) * 2005-08-09 2007-02-08 Kraft Foods Holdings, Inc. Chemoprotectants from crucifer seeds and sprouts
US20070190209A1 (en) * 2006-02-10 2007-08-16 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
US7371419B1 (en) * 2006-12-29 2008-05-13 Kraft Foods Holdings, Inc. Method of enriching glucoraphanin in radish seed preparations

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10363236B2 (en) 2011-01-03 2019-07-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US11654129B2 (en) 2011-01-03 2023-05-23 The William M Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11339125B2 (en) 2011-01-03 2022-05-24 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as NRF2 inducers to treat epidermolysis bullosa simplex and related diseases
US11306057B2 (en) 2011-01-03 2022-04-19 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US10888540B2 (en) 2011-01-03 2021-01-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10654799B2 (en) 2011-01-03 2020-05-19 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US9771322B2 (en) 2011-01-03 2017-09-26 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9828337B2 (en) 2011-01-03 2017-11-28 The William M. Yarbrough Foundation Lysine derivative having an isothiocyanate functional group and associated method of use
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US9932306B2 (en) 2011-01-03 2018-04-03 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9951005B2 (en) 2011-01-03 2018-04-24 The William M. Yarbrough Foundation Isothiocyanate functional surfactant formulation and associated method of use
US9951004B2 (en) 2011-01-03 2018-04-24 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9951003B2 (en) 2011-01-03 2018-04-24 The William M. Yarbrough Foundation Isothiocyanate functional compound and associated method of use
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10308600B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10287246B2 (en) 2011-01-03 2019-05-14 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US9585860B2 (en) 2011-01-12 2017-03-07 The William M. Yavbrough Foundation Method for treating eczema
US10111851B2 (en) 2011-01-12 2018-10-30 The William M. Yarbrough Foundation Method for treating eczema
US9649290B2 (en) 2011-01-12 2017-05-16 The William M. Yarbrough Foundation Method for treating eczema
US9655874B2 (en) 2011-01-12 2017-05-23 The William M. Yarbrough Foundation Method for treating eczema
US9687463B2 (en) 2011-01-12 2017-06-27 The William M. Yarbrough Foundation Method for treating eczema
US10532039B2 (en) 2011-02-08 2020-01-14 The William M. Yarbrough Foundation Method for treating psoriasis
US11517552B2 (en) 2011-02-08 2022-12-06 The William M. Yarbrough Foundation Method for treating psoriasis
US10765656B2 (en) 2012-07-26 2020-09-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10869854B2 (en) 2012-07-26 2020-12-22 The William M. Yarbrough Foundation Method for treating skin cancer
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10471039B2 (en) 2012-07-26 2019-11-12 The William M. Yarbrough Foundation Method for treating skin cancer
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10583108B2 (en) 2012-07-26 2020-03-10 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10583107B2 (en) 2012-07-26 2020-03-10 The William M. Yarbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US9931314B2 (en) 2012-07-26 2018-04-03 The William M. Yarbrough Foundation Method for treating skin cancer
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US11517553B2 (en) 2012-07-26 2022-12-06 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10111852B2 (en) 2012-07-26 2018-10-30 The William M. Yarbrough Foundation Method for treating bladder cancer
US10864187B2 (en) 2012-07-26 2020-12-15 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10869855B2 (en) 2012-07-26 2020-12-22 The William M. Yarbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10874630B2 (en) 2012-07-26 2020-12-29 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US11648230B2 (en) 2012-07-26 2023-05-16 The William M Yarbrough Foundation Method for treating rheumatoid arthritis
US9642827B2 (en) 2012-07-26 2017-05-09 The William M. Yarbrough Foundation Method for treating skin cancer
US9636320B2 (en) 2012-07-26 2017-05-02 The William M. Yarbrough Foundation Method for treating skin cancer
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US11633376B2 (en) 2012-07-26 2023-04-25 The William M. Yarbrough Foundation Method for treating metastatic prostate cancer
US11633375B2 (en) 2012-07-26 2023-04-25 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
CN105198782A (en) * 2015-10-23 2015-12-30 河南科技学院 Method for extracting, separating and purifying sulforaphene in radish seeds
CN105713053B (en) * 2016-03-26 2018-09-21 北京化工大学 A kind of glucosinolate extraction separation method
CN105713053A (en) * 2016-03-26 2016-06-29 北京化工大学 Extraction and separation method of glucosinolate

Also Published As

Publication number Publication date
BRPI0603903A (en) 2007-03-27
US7744937B2 (en) 2010-06-29
CA2554969A1 (en) 2007-02-09
RU2006128829A (en) 2008-02-20
RU2378002C2 (en) 2010-01-10
EP1752052A3 (en) 2007-08-29
PL1752052T3 (en) 2013-02-28
UA92140C2 (en) 2010-10-11
EP1752052B1 (en) 2012-09-12
NZ548951A (en) 2009-01-31
AU2006203321A1 (en) 2007-03-01
US20070031581A1 (en) 2007-02-08
CN1935003A (en) 2007-03-28
AU2006203321B2 (en) 2011-11-17
EP1752052A2 (en) 2007-02-14
AR054902A1 (en) 2007-07-25
NO20063553L (en) 2007-02-12

Similar Documents

Publication Publication Date Title
US7744937B2 (en) Chemoprotectants from crucifer seeds and sprouts
EP2014670B1 (en) Production of Glucosinolates from Agricultural By-Products and Waste
Sikora et al. The sources of natural antioxidants
AU710443B2 (en) Cancer chemoprotective food products
Kuti et al. Proximate composition and mineral content of two edible species of Cnidoscolus (tree spinach)
ES2704639T3 (en) Stable and bioavailable compositions of lycopene isomers for skin and hair
CN101397314B (en) Method of enriching glucoraphanin in radish seed preparations
Coppin A study of the nutritional and medicinal values of Moringa oleifera leaves from sub-Saharan Africa: Ghana, Rwanda, Senegal and Zambia
Benhassaini et al. The chemical composition of fruits of Pistacia atlantica desf. subsp. atlantica from Algeria
US20060020030A1 (en) Enhanced purity trans-lutein-ester compositions and methods of making same
Polmann et al. Non-conventional nuts: An overview of reported composition and bioactivity and new approaches for its consumption and valorization of co-products
US6770585B2 (en) Momordica cochinchinensis (Spreng.) β-carotene and method
MXPA06009031A (en) Chemoprotectants from crucifer seeds and sprouts
KR20110072772A (en) Fractionation of kimchi and preparation method thereof
Khalil et al. Chemical and technological studies on some medicinal plants
Haleem Evaluation and application of some phytochemicals in pomegranate seed residues and guava seeds
JP2000300210A (en) Carcinogenesis-suppressing extract for food
Chaichatoenaudomrung Phytochemical profile and Bioactivities of Echinocactus grusonii extract

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION